Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian S Bryzinski

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Diabetes & Vascular Disease Research|October 2, 2007
A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitusHarold Bays, Jennifer McElhattan, Brian S Bryzinski, et al.
Lancet (London, England)|December 5, 2003
The stain warsGunnar O Olsson, James W Blasetto, Brian S Bryzinski, et al.
Current Medical Research and Opinion|December 23, 2003
Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trialJames M McKenney, Peter H Jones, M Angeli Adamczyk, et al.
Trials|December 23, 2006
Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia--Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)Michael B Clearfield, John Amerena, Jean-Pierre Bassand, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Diabetes & Vascular Disease Research|October 2, 2007
A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitusHarold Bays, Jennifer McElhattan, Brian S Bryzinski, et al.
Lancet (London, England)|December 5, 2003
The stain warsGunnar O Olsson, James W Blasetto, Brian S Bryzinski, et al.
Current Medical Research and Opinion|December 23, 2003
Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trialJames M McKenney, Peter H Jones, M Angeli Adamczyk, et al.
Trials|December 23, 2006
Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia--Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)Michael B Clearfield, John Amerena, Jean-Pierre Bassand, et al.
Pageof 1